Author

Andreas Bender

University of Cambridge

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Biology Disciplines

Click to filter author papers

Bioinformatics· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Approach:benchmark study· 1 Research Focus:benchmarking· 1 Assay:bulk RNA-seq· 1 Research Focus:drug response / drug discovery· 1 Research Focus:gene regulatory network inference· 1 Approach:statistical model· 1 Assay:whole-exome sequencing· 1

Frequent Co-Authors

Alastair J.M. WatsoniD· 1 shared Albert A. AntolíniD· 1 shared Alberto CalderoneiD· 1 shared Alicia AmadoziD· 1 shared Amin AllamiD· 1 shared Amir B. K. ForoushaniiD· 1 shared Anastasios DrosouiD· 1 shared André O. FalcãoiD· 1 shared

Activity by Year

2019-2019 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBioinformatics

Alastair J.M. WatsonORCID

Author profile →

2 papers

Recent·Most cited

A systems genomics approach to uncover patient-specific pathogenic pathways in a complex disease

Johanne Brooks, Dezso Modos, Padhmanand Sudhakar, David Fazekas, Azedine Zoufir, Orsolya Kapuy, Mate Szalay-Beko, Matthew Madgwick, Bram Verstockt, Lindsay Hall, Alastair J.M. Watson, Mark Tremelling, Miles Parkes, Severine Vermeire, Andreas Bender, , Tamas Douglas Korcsmaros

This paper introduces iSNP, a workflow to identify patient-specific pathogenic pathways in ulcerative colitis by integrating SNP profiles with regulatory networks.

bioRxiv · Jul 4, 2019 · PreprintBioinformatics

A cancer pharmacogenomic screen powering crowd-sourced advancement of drug combination prediction

Michael P. Menden, Dennis Y.Q. Wang, Mike J. Mason, Bence Szalai, Krishna C. Bulusu, Yuanfang Guan, Thomas Von Yu, Jaewoo Kang, Minji Jeon, Russell D. Wolfinger, Tin Nguyen, Mikhail Zaslavskiy, Jordi Abante, Bárbara Schmitz‐Abecassis, Nanne Aben, , Denis Fourches

The paper presents a large-scale cancer pharmacogenomic screen with 11,576 experiments on 910 drug combinations across 85 cancer cell lines, enabling crowd-sourced prediction of synergistic drug pairs and biomarkers.

Nature Communications · Jun 17, 2019Peer-reviewedBioinformatics